Intravenously administered nanoparticles increase survival following blast trauma. - Wikidata - awgldk - TriplyDB

Intravenously administered nanoparticles increase survival following blast trauma.

Intravenously administered nanoparticles increase survival following blast trauma.

http://www.wikidata.org/entity/Q30584438

about

Alternatives to allogeneic platelet transfusion.Non-affinity factors modulating vascular targeting of nano- and microcarriers Hemostatic Nanoparticles Improve Survival Following Blunt Trauma Even after 1 Week Incubation at 50 °C.Halting hemorrhage with self-propelling particles and local drug delivery.Mimicking biological functionality with polymers for biomedical applications.Bio-inspired nanomedicine strategies for artificial blood components.Steroid-Loaded Hemostatic Nanoparticles Combat Lung Injury after Blast Trauma.Blast Wave Exposure to the Extremities Causes Endothelial Activation and Damage.Biomaterials and Advanced Technologies for Hemostatic Management of Bleeding.Hemostasis and nanotechnology.Intravenous administration of synthetic platelets (SynthoPlateTM) in a mouse liver injury model of uncontrolled hemorrhage improves hemostasis.Enhancing clot properties through fibrin-specific self-cross-linked PEG side-chain microgels

P2860

Q33435484-0DAAEDBD-C238-454E-86AF-849BF57A4C79 Q36703526-DCB522AC-EA1E-44F0-A6C5-75E66E2753C6 Q37278074-2B0A1761-DE3D-4F91-83DF-6D698B1CD890 Q38840359-44751D24-8C5B-4E1F-842B-E10C7E4D8742 Q39038679-0738680A-5240-4652-BD54-53A6C6CD036B Q39179984-355FC7ED-6349-4032-B8BC-C34AAE6DE124 Q41156067-4796F495-3278-411F-AD15-89A816CFEACF Q41872130-B98296BE-ACCF-4344-AAC3-FDE198E90F8C Q47324534-2183FDE5-2954-49FC-BCAE-C6E8ED57CAB6 Q49247169-2F3E01E4-821F-4DBB-BA11-C86D3D97DE4E Q51740307-8A52EC32-8B43-49D4-83E8-BEFD0490EA84 Q56365154-A40CCE5F-FD5B-4C1B-A09F-B1AFE7271B42

P2860

Intravenously administered nanoparticles increase survival following blast trauma.

http://www.wikidata.org/entity/Q30584438

description

2014 nî lūn-bûn

@nan

2014 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Intravenously administered nanoparticles increase survival following blast trauma.

@ast

Intravenously administered nanoparticles increase survival following blast trauma.

@en

type

label

Intravenously administered nanoparticles increase survival following blast trauma.

@ast

Intravenously administered nanoparticles increase survival following blast trauma.

@en

prefLabel

Intravenously administered nanoparticles increase survival following blast trauma.

@ast

Intravenously administered nanoparticles increase survival following blast trauma.

@en

P1433

Q30584438-E034BFC3-CB71-4B07-A285-043803B8AE6C

P1476

Q30584438-BA51D6C7-8383-46CB-82AA-5F08E9B92EBB

P2093

Q30584438-1A76D09A-D340-4D7C-80B9-924277E7E55E

Q30584438-6FBEBA81-22E4-4DFB-8B2D-28A94C6ABA40

Q30584438-72121EC2-2920-4648-95D9-6D5B6EAA0873

Q30584438-8141F465-8BBC-4660-85FB-CCFD59A8F298

Q30584438-8EB30552-273A-459E-8BDA-4F46CA899611

Q30584438-C335F614-C6AB-47A9-A9E7-DA3FB2BD0001

Q30584438-C7310E56-DDB0-41A4-B9F7-5E9683FB22FF

P2860

Q30584438-02494320-3EB6-47C1-8EE9-17B40EAF05AF

Q30584438-07A7B70A-2DA2-4488-8C28-1D9F0558C397

Q30584438-09BDC887-070E-4ED3-8FD0-E700942374A7

Q30584438-1B39B46E-D8B4-4578-9B4A-2D7DFC67B550

Q30584438-2119A3BC-1082-4FEA-BC6C-383EF1535357

Q30584438-2254DCA0-8DC7-4ABE-908C-FD68E4CC4604

Q30584438-299CC64C-D952-42E8-A260-76DC1F6CDB4F

Q30584438-2B7D697E-35BF-40C1-A7C3-223007994F89

Q30584438-2CEBBDAD-D589-4EA4-8042-9C4382BE6D50

Q30584438-635524DA-F750-4B0E-9150-56976E44787F

P304

Q30584438-3031B676-73D0-45FE-AB0A-362C61E2B96E

P31

Q30584438-C023228A-BF90-4B44-9C19-82F44D21E046

P356

Q30584438-53B61B35-11CB-4E3E-A616-CE7998102872

P407

Q30584438-1CB17315-44B0-4E23-B2BA-2E4C0E5708A1

P433

Q30584438-72730615-30FA-4147-9715-2FD136092DD9

P478

Q30584438-7C95C069-EA57-448B-B5CB-0AE4F6D9E6A8

P577

Q30584438-69380E3F-928B-468B-A12A-8022BE4F0F8F

P5875

Q30584438-14AD44F0-3F2B-47A9-A710-42269574AD30

P698

Q30584438-3897703A-72E3-4DFD-914C-58101876807D

P921

Q30584438-BDADA2CD-F369-4853-8A9E-E7BED14EDA22

P932

Q30584438-3A7EDDB8-71DD-4FB1-ADEB-C91B64CCE4E7

P356

PNAS.1406979111

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Intravenously administered nanoparticles increase survival following blast trauma.

@en

P2093

Cynthia Bir

http://www.w3.org/2001/XMLSchema#string

Erin B Lavik

http://www.w3.org/2001/XMLSchema#string

Erin Shoffstall

http://www.w3.org/2001/XMLSchema#string

Kristyn T Atkins

http://www.w3.org/2001/XMLSchema#string

Margaret M Lashof-Sullivan

http://www.w3.org/2001/XMLSchema#string

Nickolas Keane

http://www.w3.org/2001/XMLSchema#string

Pamela VandeVord

http://www.w3.org/2001/XMLSchema#string

P2860

Hemostatic effects of phospholipid vesicles carrying fibrinogen gamma chain dodecapeptide in vitro and in vivo.

Visualization of liposomes carrying fibrinogen gamma-chain dodecapeptide accumulated to sites of vascular injury using computed tomography.

Toxicology of blast overpressure.

Fibrinogen-coated albumin microcapsules reduce bleeding in severely thrombocytopenic rabbits.

Explosions and blast injuries.

Death on the battlefield (2001-2011): implications for the future of combat casualty care.

A profile of combat injury.

Thromboerythrocytes. In vitro studies of a potential autologous, semi-artificial alternative to platelet transfusions

Treating traumatic bleeding in a combat setting: possible role of recombinant activated factor VII.

Use of recombinant factor VIIa for adjunctive hemorrhage control in trauma and surgical patients.

P304

10293-10298

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.1406979111

http://www.w3.org/2001/XMLSchema#string

P407

P433

28

http://www.w3.org/2001/XMLSchema#string

P478

111

http://www.w3.org/2001/XMLSchema#string

P577

2014-06-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

263585419

http://www.w3.org/2001/XMLSchema#string

P698

24982180

http://www.w3.org/2001/XMLSchema#string

P921

P932

4104920

http://www.w3.org/2001/XMLSchema#string